The U.S. Food and Drug Administration (FDA) permitted sale of a device—the BSD-2000—which is used to combat cervical cancer in women who are too ill to undergo chemotherapy. At issues is that the device has not been fully tested.
The BSD-2000 uses intense heat to kill off cancer cells and is only used in very specific circumstances when women are extremely ill from cervical cancer, according to The New York Times. In the two years since the device was sold, those few hospitals that purchased the BSD-2000, a $500,000 device, have not participated in a patient study that the manufacturer agreed to perform as part of the device’s approval. In fact, cancer experts have said they were surprised the regulators cleared the BSD-200 to begin with. Continue reading
A recent study reveals that consumption of sugary drinks is tied to an increased risk of endometrial cancer in post-menopausal women.
Prior research also found an association between sugar-sweetened beverages and Type 2 diabetes; however, this is the first study to see the same tie with a specific type of endometrial cancer, according to The New York Times Well blog. Continue reading
The U.S. Food and Drug Administration (FDA) just issued a Safety Communication that warns the public that Onfi (clobazam), an anti-seizure medication, can lead to the rare, but very serious skin reaction, Stevens-Johnson syndrome (SJS). SJS can be fatal and can lead to permanent injury.
SJS and Toxic Epidermal Necrolysis (TEN) are usually the result of medication use and are potentially fatal disorders that involve cell death in the skin and mucus membranes. SJS blistering of the mucous membranes usually occurs in the mouth, eyes, and vagina; blistering can spread to internal organs. SJS can also cause patchy areas of rash that ultimately peel off the skin, scarring, and blindness. TEN is a very severe form of SJS and occurs when over 30 percent of the body is involved. Both SJS and TEN typically require hospital burn unit treatment. Continue reading
IQ Formulations, of Sunrise, Florida, is initiating a voluntary recall of all lots of its 45-capsule bottles of Hydravax due to the inclusion of an unlisted ingredient.
The U.S. Food and Drug Administration (FDA) advised IQ Formulations that an analysis of a sample from Hydravax Lot #2458 (Exp # 07/16) revealed the presence of an undeclared ingredient, identified as a diuretic. Diuretics are prescription drugs. The product is sold nationwide in stores and by mail order in 45-capsule bottles, to aid in weight loss by eliminating water weight. Continue reading
Research recently reported in the British Medical Journal (BMJ) links an increased risk of heart attacks and strokes to the use of effervescent, soluble medicines.
A research team from Britain’s University of Dundee and University College London found that people taking the maximum daily dose of some “fizzy” versions of painkillers, vitamin supplements, or other common medicines would exceed the daily recommended limits for sodium, Reuters reports. This does not take into account other daily sodium sources. Continue reading
Close to half of the babies that are born using advanced fertility methods are part of multiple births—twins, triplets, etc.—according to emerging federal figures.
While large multiple births have dropped, likely following the notorious “Octomom” case, writes The Associated Press (AP), twin births continue to occur at the same rate. At issue, according to fertility specialists, is that twins have increased risks for significant health problems, including higher risks for premature births. Continue reading
The Metro-North commuter train that derailed in the Bronx just about 10 miles outside of New York City was traveling at high speeds as it went into a curve just before jumping the tracks.
At the 30 mile-per-hour (mph) curve, the train was speeding at 82 mph, according to initial information, the National Transportation Safety Board (NTSB) just said, according to FoxNews. Earl Weener, NTSB board member, stated that it is too early to say if human or equipment error led to the deadly crash. “That’s the question we need to answer,” Weener said at a news conference.
Four people died and dozens were injured in the crash. Continue reading
The current practice of giving a drug two names—a brand name and a generic name – can confuse practitioners and increase the chance of medication errors.
Almost all medications have a brand name that remains under patent protection for 20 years, during which the patent holder is the sole manufacturer and distributor. When the patent expires and the drug goes generic, drug makers can manufacture the drug under the generic name, but the generic name is often very different from the brand name that the public has come to know, according to The New York Times’ Well blog. The price of the generic tends to be less and for this reason insurance plans favor generics. The original manufacturer retains the brand name and tries to keep that name in use because drug makers know people tend to trust brand name drugs more. Continue reading
This weekend, a Metro-North commuter train derailed in Bronx, New York, leaving four people dead and injuring dozens more, according to investigators.
The train derailed in a curve on the tracks, causing the locomotive and all seven passenger cars to jump the track near the Spuyten Duyvil station, which is about 10 north of the Grand Central Terminal in Manhattan, according to CNN, citing the National Transportation Safety Board (NTSB).
Three of the passengers who died were thrown from the train as it “came off the track and was twisting and turning,” New York Fire Department Chief Edward Kilduff told reporters, according to the CNN report. Amanda Swanson, who survived the crash, told CNN that the windows of the cars broke out and that, “the gravel came flying up in our faces.” Continue reading
Abbott Labs just issued a recall of some of its FreeStyle® and FreeStyle Lite® Blood Glucose Test Strips in the United States, according to the U.S. Food and Drug Administration (FDA).
The recall involves 20 lots of FreeStyle® and FreeStyle Lite® Blood Glucose Test Strips, which might produce erroneously low blood glucose results when used with the ”FreeStyle® Blood Glucose Meter,” the “FreeStyle® Flash Blood Glucose Meter,” or the OmniPod® Insulin Management System. Neither the “FreeStyle® Blood Glucose Meter” nor the “FreeStyle® Flash Blood Glucose Meter” have been in production since 2010. Continue reading